Name : Mrs.

ARCHANA Barcode No : 60008182

Age/Gender : 22 YRS/Female Reg. No : 00012305210018
Referred by : SHREE HOSPITAL Collected On : 05/Sep/2023 11:35 AM
Referring Centre : OPL016-SHREE HOSPITAL Received On : 05/Sep/2023 07:42 PM
Sample Type : Whole Blood EDTA Reported On : 06/May/2023 12:46PM
Report Status : Final

HAEMATOLOGY
Test Name Result Unit Biological Ref.Interval
OSCAR 1.3
Complete Blood Count (CBC)+ESR
HAEMOGLOBIN (Hb) 11.4 gm/dl 11.5-16.0
Methodology: SLS-Haemoglobin Method

TOTAL LEUKOCYTE COUNT (TLC) 8.1 th/cumm 4.0-10.0

Methodology: Fluorescence flow cytometry

DIFFERENTIAL LEUCOCYTE COUNT

POLYMORPHS 55 % 40-75
Methodology: Fluorescence flow cytometry

LYMPHOCYTES 35 % 20-40
Methodology: Fluorescence flow cytometry/Manual

EOSINOPHILS 04 % 1-6
Methodology: Fluorescence flow cytometry

MONOCYTES 06 % 2-10
Methodology: Fluorescence flow cytometry

BASOPHILS 00 % 0-1
Whole Blood EDTA Flowcytometry

ABSOLUTE NEUTROPHIL COUNT 4,455 /cumm 1600 - 8000

Methodology: Calculated

ABSOLUTE LYMPHOCYTE COUNT 2,835 /cumm 1392 - 3510

Methodology: Calculated

ABSOLUTE EOSINOPHIL COUNT 324 /cumm 40-440

Methodology: Calculated

ABSOLUTE MONOCYTE COUNT 486 /cumm 100-900

Methodology: Calculated

ABSOLUTE BASOPHIL COUNT 0 /cumm 0-100

Methodology: Calculated

RED BLOOD CELLS - RBC COUNT 4.0 millions/cmm 3.8-4.8

Methodology: DC detection method

HCT 33.2 % 35-45

Whole Blood EDTA, Calculated

MCV 82 fl 76-96
Methodology: Automated/Calculated

MCH 28.1 pg 27-33

Methodology: by Automated/Calculated

Page 1 of 10
Name : Mrs.ARCHANA Barcode No : 60008182
Age/Gender : 22 YRS/Female Reg. No : 00012305210018
Referred by : SHREE HOSPITAL Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016-SHREE HOSPITAL Received On : 21/May/2023 11:42 AM
Sample Type : Whole Blood EDTA Reported On : 21/May/2023 12:46PM
Report Status : Final

MCHC 34.3 g/dl 30-35

Methodology: Automated/Calculated

PLATELET COUNT 155 thou/µL 150-450

Methodology: DC detection method

unit
MEAN PLATELET VOLUME - MPV 11.7 fl 7.4-10.4
Methodology: Plt Histogram

RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.9 % 11.5-14.5

Methodology: Automated/Calculated
Whole Blood EDTA, Flowcytometry

RED CELL DISTRIBUTION WIDTH (RDW-SD) 49.7 fl 35-56

Methodology: Automated/Calculated
Whole Blood EDTA, Flowcytometry

PCT(PLATELETCRIT) 0.2 % 0.10-0.28

Methodology: Calculated

PDW-SD 19.5 fl 9.00-17.00

Methodology: Calculated
Whole Blood EDTA, Calculated

NEUTROPHIL - LYMPHOCYTE RATION (NLR) 1.57

Calculated

LYMPHOCYTE - MONOCYTE RATIO (LMR) 5.83

Calculated

PLATELET - LYMPHOCYTE RATIO (PLR) 54.67

ESR [WESTERGREN] 20 mm/ 1 hr 0 -10
MODIFIED WESTERGREN

*** End Of Report ***

Page 2 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Whole Blood EDTA Reported On : 21/May/2023 12:44PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

HbA1c (Glycated hemoglobin)
Glycosylated Hb (HbA1c) 5.2 % 4.2-6.0
EDTA BLOOD, HPLC Assay

Average Glucose 103 mg/dl 0-125

Calculated.

INTERPRETATION

The following Hb A1c ranges may be used for interpretation of results ; however, factors such as
duration of diabetes, adherence to therapy & the age of the patient should also be considered in
assessing the degree of blood glucose control. These values are for nonpregnant individuals.
Hemoglobin A1c (%) Degree of Glucose Control
> 8 Action Suggested *
< 7 Goal **
< 6 Non - diabetic Level
* High risk of developing long term complications such as retinopathy, nephropathy & cardiopathy.
Action suggested depends on individual patient circumstances.
** Some danger of hypoglycemic reaction in Type 1 diabetics. Some glucose intolerant indivduals &
"sub - clinical" diabetics may demonstrate (elevated) HbA1c in this area.
Estimation of Mean Plasma Glucose (MPG)
Further clinical information may be derived from the HbA1c value by using it to estimate the mean
plasma glucose (MPG) level over the last 60 days.
This estimation may not be used with the less specific methods (total HbA1c & total glycated Hb) since
the correlation of the HbA1a and HbA1b fractions with long - term glucose control is very questionable.
HbA1c (%) MPG Estimate ( mg/dl).
6.0 135
7.0* 170
9.0 240
*ADA Target
Non - diabetic (Normal) Range
The weighted mean HbA1c for patients with normal fasting plasma glucose was 5.17% with the standard
deviation of 0.45%.

*** End Of Report ***

Page 3 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Serum Reported On : 21/May/2023 01:28PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

BIOCHEMISTRY
IRON PROFILE BASIC
Iron 39.3 ug/dl 37-145
Serum, FerroZine without deproteinization

TIBC* 325.2 ug/dL 250-400

Calculatedl

UIBC* 285.9 ug/dL 63 - 433

Serum, Biochemical

Transferrin Saturation * 12.08 % 15-55

Calculated

COMMENT:

Serum iron measures the amount of circulating iron that is bound to transferrin. Clinicians order this laboratory test when they are
concerned about iron deficiency, which can cause anemia and other problems.

Total iron-binding capacity The test measures the extent to which iron-binding sites in the serum can be saturated. Because the iron-
binding sites in the serum are almost entirely dependent on circulating transferrin, this is really an indirect measurement of the amount of
transferrin in the blood. Taken together with serum iron and percent transferrin saturation clinicians usually perform this test when they
are concerned about anemia, iron deficiency or iron deficiency anemia. However, because the liver produces transferrin, liver function
must be considered when performing this test. It can also be an indirect test of liver function, but is rarely used for this purpose.

*** End Of Report ***

Page 4 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Serum Reported On : 21/May/2023 12:26PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

KIDNEY FUNCTION TEST (KFT)
Urea 64.2 mg/dL 9-45
Serum, Urease, GLDH

Creatinine. 0.7 mg/dL 0.5-1.3

Serum, Jaffes

Uric Acid 3.2 mg/dl 2.3-6.0

Serum, Uricase

Sodium 139.6 mmol /L 135 - 148

Serum, Ion Selective Electrode

Potassium 4.6 mmol /L 3.7-5.5

Serum, Ion Selective Electrode

Chloride 101.3 mmol /L 98-107

Serum, Ion Selective Electrode

Calcium 8.9 mg/dl 8.4-10.3

Serum, NM BAPTA

Phosphorous Serum 3.2 mg/dl 2.6-4.5

BUN (Blood Urea Nitrogen ) 30 mg/dl 6.0-20.0
Serum, Calculated

BUN/Creatinine Ratio 42.86 Ratio 10-20

Serum, Calculated

Urea/Creatinine Ratio 91.71 Ratio

Serum, Calculated

*** End Of Report ***

Page 5 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Serum Reported On : 21/May/2023 12:26PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

LIPID PROFILE
Cholesterol 292 mg/dl <200
Serum, CHOD-PAP Enzymatic

Triglyceride 178 mg/dl <150

Serum, GPO, Colorimetric

HDL-Cholesterol 51.2 mg/dl 40-60

Serum, Homogeneous Enz.Colorimetric

LDL Cholesterol 205.2 mg/dl 0-100

Serum, Calculated

VLDL Cholesterol 35.6 mg/dl 5 - 40

Serum, Calculated

LDL / HDL Ratio 4.01 0 - 3.55

Serum, Calculated

HDL / LDL Ratio 0.25 >0.3

Serum, Calculated

Chol / HDL Ratio 5.7 0 - 4.97

Serum, Calculated

Non-HDL Cholesterol 240.8 mg/dl <160

Serum, Calculated
Lipids are a group of fats and fat-like substances that are important constituents of cells and sources of energy. The lipid profile is used as part of a cardiac risk
assessment to help determine an individual's risk of heart disease. It is recommended that healthy adults with no other risk factors for heart disease be tested with a
fasting lipid profile once every four to six years. If other risk factors are present or if previous testing revealed a high cholesterol level in the past, more frequent
testing is recommended.

TOTAL
(mg/dL) HDL (mg/dL) LDL (mg/dL) TRIGLYCERIDES (mg/dL)
CHOLESTEROL
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

VERY HIGH >190

*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES

*** End Of Report ***

Page 6 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Serum Reported On : 21/May/2023 12:26PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

LIVER FUNCTION TEST (LFT)
Total Bilirubin 1.5 mg/dl 0.1-1.2
Serum, DCA

Conjugated Bilirubin 0.4 mg/dl 0.0-0.3

Serum, DCA

Unconjugated Bilirubin 1.1 mg/dl <1.10

Serum, Calculated

SGOT (AST) 60.8 IU/L 0 -32

Serum, Optimized UV test with IFCC

SGPT (ALT) 74.5 IU/L 0-31

Serum, Optimized UV test with IFCC

Alk.Phosphatase 62.6 IU/L 35-104

Serum, Kinetic, IFCC

T.Protein 6.8 gm/dl 6.4-8.3

Serum, Biuret

Albumin 5.2 gm/dl 3.5-5.2

Serum, Bromocresol Green

Globulin 1.6
Serum, Calculated

A/G Ratio 3.25

Serum, Calculated

SGOT/SGPT Ratio 0.82 Ratio 0-5

Serum, Calculated

COMMENTS:

A liver panel (Liver function test) or one or more of its component tests may be used to help diagnose liver disease if a
person has symptoms that indicate possible liver dysfunction. If a person has a known condition or liver disease, testing
may be performed at intervals to monitor liver status and to evaluate the effectiveness of any treatments.

*** End Of Report ***

Page 7 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Fluoride Plasma Reported On : 21/May/2023 12:43PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

SUGAR FASTING
Blood Sugar Fasting 102 mg/dl 70-110
Plasma Fluoride, Hexokinase

COMMENTS:

Fasting Blood Sugar/Glucose test. A blood sample will be taken after an overnight fast. A fasting blood sugar level less than 100 mg/dL is
normal. A fasting blood sugar level from 100 to 125 mg/dL is considered prediabetes. If it's 126 mg/dL or higher on two separate tests,
you have diabetes. (American Diabetes Association)

*** End Of Report ***

Page 8 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Serum Reported On : 21/May/2023 03:56PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

IMMUNOASSAY
Thyroid Profile-I [T3,T4,TSH]
T3 (Trilodothyronine) 110.5 ng/dl 80-220
Serum, Electro Chemi Luminescent Immuno Assay

T4 (Thyroxine) 8.3 ug/mL 5.0-12.0

Serum, Electro Chemi Luminescent Immuno Assay

TSH (Ultrasensitive) 9.519 mlU/mL 0.35-5.20

Serum, Electro Chemi Luminescent Immuno Assay
Below mentioned are the guidelines for age reference ranges for T3,T4 and TSH results:
Age Total T3 (ng/dl) Total T4 ( µg/dl) TSH (µlU/ml)
1 - 6 days 73 - 288 5.04 - 18.5 0.7 - 15.0
6 days -3 months 80 - 275 5.41 - 17.0 0.72 - 11.0
4 - 12 months 86 - 265 5.67 - 16.0 0.73 - 8.35
1 - 6 years 92 - 248 5.95 - 14.7 0.70 - 5.97
7 - 11 years 93 - 231 5.99 - 13.8 0.60 - 5.84
12 - 20 years 91 - 218 5.91 - 13.2 0.51 - 6.50
>20 years 60 - 181 4.50 - 12.6 0.13 - 6.33
TSH Level in pregnancy
First Trimester 0.10 – 2.5 µlU/ml
Second Trimester 0.20 – 3.0 µlU/ml
Third Trimester 0.30 – 3.0 µlU/ml

*** End Of Report ***

Page 9 of 10
Name : Mrs.AAMEENA Barcode No : 60008182
Age/Gender : 62 YRS/Female Reg. No : 00012305210018
Referred by : SELF Collected On : 21/May/2023 11:35 AM
Referring Centre : OPL016C-NITESH KUMAR Received On : 21/May/2023 11:42 AM
Sample Type : Serum Reported On : 21/May/2023 01:29PM
Report Status : Final

Test Name Result Unit Biological Ref.Interval

Vitamin B12 (Cynocobalamin)
Vitamin B12 Level 285.3 pg/ml 180-916
Serum, Electro Chemi Luminescent Immuno Assay

Comment:
Vitamin B12 (cobalamin) is an important water-soluble vitamin. In contrast to other water-soluble vitamins it is not excreted quickly in
the urine, but rather accumulates and is stored in the liver, kidney and other body tissues. Humans obtain Vitamin B12 exclusively from
animal dietary sources, such as meat, eggs and milk. As a result, a vitamin B12 deficiency may not manifest itself until after 5 or 6
years of a diet supplying inadequate amounts. Vitamin B12 functions as a methyl donor and works with folic acid in the synthesis of
DNA and red blood cells and is vitally important in maintaining the health of the insulation sheath (myelin sheath) that surrounds nerve
cells. Preservatives such as fluorides & ascorbic acid interfere with this assay. Excessive exposure of the specimen to light may alter
Vitamin B12 result.
Kindly correlate with clinical conditions.

Vitamin D (25-hydroxycholecalciferol)
Vitamin D, 25 Hydroxy 21.2 ng/mL 30-100
Serum, Chemi Luminescent Immuno Assay

Reference Range :
DEFICIENCY : <20 ng/ml
INSUFFICIENCY : 20-30 ng/ml
NORMAL : 30-100 ng/ml

Comments:
This test is used to determine the levels of 25-hydroxy-vitamin D and is used to determine if bone weakness, bone malformation, or abnormal metabolism of calcium is
occurring as a result of a deficiency or excess of vitamin D. Since vitamin D is a fat-soluble vitamin and is absorbed from the intestine like a fat, vitamin D is also s used
to monitor individuals with diseases that interfere with fat absorption, such as cystic fibrosis and Crohn's disease, and in patients who have had gastric bypass surgery and
may not be able to absorb enough Vitamin D. Vitamin D is also used to determine effectiveness of treatment when vitamin D, calcium, phosphorus, and/or magnesium
supplementation is prescribed. Reasons for suboptimal 25-OH-VitD levels include lack of sunshine exposure, inadequate intake; malabsorption eg, due to Celiac disease);
depressed hepatic vitamin D 25-hydroxylase activity, secondary to advanced liver disease; and enzyme-inducing drugs, in particular many antiepileptic drugs, including
phenytoin, phenobarbital, and carbamazepine, that increase 25-OH-VitD metabolism. In contrast to the high prevalence of 25-OH-VitD deficiency, hypervitaminosis D
is rare, and is only seen after prolonged exposure to extremely high doses of vitamin D. When it occurs, it can result in severe hypercalcemia and hyperphosphatemia.
Kindly correlate with clinical conditions.

*** End Of Report ***

Page 10 of
10